Astoul E, Watton S, Cantrell D
Lymphocyte Activation Laboratory, Imperial Cancer Research Fund, London WC2A 3PX, United Kingdom.
J Cell Biol. 1999 Jun 28;145(7):1511-20. doi: 10.1083/jcb.145.7.1511.
This study has used biochemistry and real time confocal imaging of green fluorescent protein (GFP)-tagged molecules in live cells to explore the dynamics of protein kinase B (PKB) regulation during B lymphocyte activation. The data show that triggering of the B cell antigen receptor (BCR) induces a transient membrane localization of PKB but a sustained activation of the enzyme; active PKB is found in the cytosol and nuclei of activated B cells. Hence, PKB has three potential sites of action in B lymphocytes; transiently after BCR triggering PKB can phosphorylate plasma membrane localized targets, whereas during the sustained B cell response to antigen, PKB acts in the nucleus and the cytosol. Membrane translocation of PKB and subsequent PKB activation are dependent on BCR activation of phosphatidylinositol 3-kinase (PI3K). Moreover, PI3K signals are both necessary and sufficient for sustained activation of PKB in B lymphocytes. However, under conditions of continuous PI3K activation or BCR triggering there is only transient recruitment of PKB to the plasma membrane, indicating that there must be a molecular mechanism to dissociate PKB from sites of PI3K activity in B cells. The inhibitory Fc receptor, the FcgammaRIIB, mediates vital homeostatic control of B cell function by recruiting an inositol 5 phosphatase SHIP into the BCR complex. Herein we show that coligation of the BCR with the inhibitory FcgammaRIIB prevents membrane targeting of PKB. The FcgammaRIIB can thus antagonize BCR signals for PKB localization and prevent BCR stimulation of PKB activity which demonstrates the mechanism for the inhibitory action of the FcgammaRIIB on the BCR/PKB response.
本研究利用生物化学方法以及对活细胞中绿色荧光蛋白(GFP)标记分子进行实时共聚焦成像,来探究B淋巴细胞激活过程中蛋白激酶B(PKB)调控的动力学。数据显示,B细胞抗原受体(BCR)的触发诱导了PKB的短暂膜定位,但该酶持续激活;在活化B细胞的细胞质和细胞核中发现了活性PKB。因此,PKB在B淋巴细胞中有三个潜在作用位点;BCR触发后,PKB可短暂磷酸化质膜定位的靶点,而在B细胞对抗原的持续反应过程中,PKB在细胞核和细胞质中发挥作用。PKB的膜转位及随后的PKB激活依赖于BCR对磷脂酰肌醇3激酶(PI3K)的激活。此外,PI3K信号对于B淋巴细胞中PKB的持续激活既是必需的也是充分的。然而,在持续的PI3K激活或BCR触发条件下,PKB仅短暂募集到质膜,这表明在B细胞中必须存在一种分子机制使PKB与PI3K活性位点解离。抑制性Fc受体FcγRIIB通过将肌醇5磷酸酶SHIP募集到BCR复合物中来介导B细胞功能的重要稳态控制。在此我们表明,BCR与抑制性FcγRIIB的共结合可阻止PKB的膜靶向。因此,FcγRIIB可拮抗BCR针对PKB定位的信号,并阻止BCR对PKB活性的刺激,这证明了FcγRIIB对BCR/PKB反应抑制作用的机制。